Biosimilars in the UK: where are we now and where does the NHS want to go?
Four Key Reasons to Attend SMi’s 2019 Biosimilars
10 Key Reasons to attend Biosimilars
innovation and breakthroughs at all levels at DDF’19
Exclusive interview with expert speaker from ASBM